Pitchbook released their “Second Quarter 2013 U.S. Venture Capital Data” last week, and the outlook for medical device venture deals continues to be difficult. Based on first half actual data, Pitchbook forecasts that the total number of early stage device deals in 2013 will hit a six-year low – a steep drop from 2012 and about half of the 2008 peak. Pitchbook forecasts that the number of late stage deals will drop, but not as far – slightly down from 2012 and only at a five-year low. Unfortunately, I can’t say I’m surprised.
Source: full report here.
- Q2 Venture Capital Investments in Early-Stage Healthcare Companies Reach Five-Quarter High
- Med tech VC investing remains sluggish, biotech surges
- Despite mixed trends in general VC funding, health tech continues to boom